Skip to main content
. 2021 Sep 20;8:728496. doi: 10.3389/fmed.2021.728496

Figure 5.

Figure 5

Roadmap to clinical translation of MSC therapies for kidney disease, from MSC manufacturing variables to therapeutical benefits in renal pathologies.